These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10577351)

  • 1. Mechanisms of quinolone resistance in clinical isolates of Shigella dysenteriae.
    Ahamed J; Gangopadhyay J; Kundu M; Sinha AK
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2333-4. PubMed ID: 10577351
    [No Abstract]   [Full Text] [Related]  

  • 2. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae.
    Ghosh AS; Ahamed J; Chauhan KK; Kundu M
    Biochem Biophys Res Commun; 1998 Jan; 242(1):54-6. PubMed ID: 9439608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a fluoroquinolone resistant Shigella dysenteriae 1 strain from Calcutta.
    Chunder N; Bhattacharya SK; Biswas D; Niyogi SK; Kumar R
    Indian J Med Res; 1997 Dec; 106():494-6. PubMed ID: 9439093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR.
    Rahman M; Mauff G; Levy J; Couturier M; Pulverer G; Glasdorff N; Butzler JP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2488-91. PubMed ID: 7840594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.
    Dutta S; Kawamura Y; Ezaki T; Nair GB; Iida K; Yoshida S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1660-1. PubMed ID: 15793166
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA; Jesudason MV; John TJ
    Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutator plasmid in a nalidixic acid-resistant strain of Shigella dysenteriae type 1.
    Ambler JE; Drabu YJ; Blakemore PH; Pinney RJ
    J Antimicrob Chemother; 1993 Jun; 31(6):831-9. PubMed ID: 8360123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 12. Nalidixic-acid resistant Shigella dysenteriae type 1 in eastern India.
    Sen D; Dutta P; Deb BC; Pal SC
    Lancet; 1988 Oct; 2(8616):911. PubMed ID: 2902361
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistant Shigella dysenteriae.
    Panhotra BR; Desai B
    Lancet; 1983 Dec; 2(8364):1420. PubMed ID: 6140517
    [No Abstract]   [Full Text] [Related]  

  • 14. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones.
    Sarkar K; Ghosh S; Niyogi SK; Bhattacharya SK
    Lancet; 2003 Mar; 361(9359):785. PubMed ID: 12620764
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia.
    Ashraf MM; Ahmed ZU; Sack DA
    Can J Microbiol; 1991 Jan; 37(1):59-63. PubMed ID: 2021898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological investigation of diarrhoea epidemics among Rwandan refugees in Zaire.
    Islam MS; Siddique AK; Salam A; Akram K; Majumdar RN; Zaman K; Fronczak N; Laston S
    Trans R Soc Trop Med Hyg; 1995; 89(5):506. PubMed ID: 8560524
    [No Abstract]   [Full Text] [Related]  

  • 17. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh.
    Naheed A; Kalluri P; Talukder KA; Faruque AS; Khatun F; Nair GB; Mintz ED; Breiman RF
    Lancet Infect Dis; 2004 Oct; 4(10):607-8. PubMed ID: 15451486
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of subinhibitory concentrations of some quinolones on a strain of Shigella dysenteriae type 1.
    Hostacká A; Karelová E
    Arzneimittelforschung; 1998 Feb; 48(2):185-7. PubMed ID: 9541731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.
    Hoge CW; Gambel JM; Srijan A; Pitarangsi C; Echeverria P
    Clin Infect Dis; 1998 Feb; 26(2):341-5. PubMed ID: 9502453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.